Rafferty Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $349K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $302K | Buy |
|
|||||
|
2021
Q3 | $686K | Buy |
|
|||||
|
2021
Q2 | $368K | Buy |
|
|||||
|
2021
Q1 | $250K | Sell |
|
|||||
|
2020
Q4 | $419K | Sell |
|
|||||
|
2020
Q3 | $365K | Buy |
|
|||||
|
2020
Q2 | $286K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $403K | Sell |
|
|||||
|
2019
Q3 | $260K | Buy |
|